INSM

Q: What is the price of Insmed (INSM) today?

The current price of Insmed (INSM) is $109.49. The stock began the year trading around $174.04 and is currently priced at $109.49. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Insmed (INSM) pay dividends?

Insmed (INSM) did not pay dividends over the past year.

Q: Is Insmed (INSM) a good investment?

Insmed (INSM) is currently trading at $109.49 with a P/E ratio of -20.76. This represents a -1,574% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 11.52%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

Insmed Incorporated

Price

$109.49

return (12m)

11.52%

p/e

-20.76

p/bv

34.87

DIVIDEND YIELD

0.00%

INSM price

Insmed

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment INSM

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

11.90%

3 months

-27.56%

1 year

11.52%

2 years

42.73%

5 years

299.74%

10 years

860.44%

Fundamentals INSM

review the fundamentals of Insmed shares

P/E

-20.76

Sector: -4.18 Industry: -4.18

P/Revenue (PSR)

29.99

Sector: -4.11 Industry: -4.11

P/BV

34.87

Sector: 2.10 Industry: 2.10

Dividend Yield (DY)

0.00%

Sector: - Industry: -

Payout

Sector: - Industry: -

Net Profit Margins

-100.00%

Sector: -39.67% Industry: -39.67%

Gross Margin

81.56%

Sector: 36.44% Industry: 36.44%

Operating Margin

-100.00%

Sector: -38.52% Industry: -38.52%

EBIT Margin

-67.10%

Sector: - Industry: -

EBITDA Margin

-65.46%

Sector: - Industry: -

EV/EBITDA

Sector: - Industry: -

EV/EBIT

Sector: - Industry: -

P/EBITDA

-21.22

Sector: -4.34 Industry: -4.34

P/EBIT

-20.89

Sector: -4.39 Industry: -4.39

P/Total Assets

11.84

Sector: 1.50 Industry: 1.50

P/Working Capital

Sector: - Industry: -

P/Net Current Assets

Sector: - Industry: -

BVPS

3.27

Sector: 1.92 Industry: 1.92

EPS

-5.49

Sector: -2.17 Industry: -2.17

Asset Turnover

0.15

Sector: - Industry: -

ROE

-167.94%

Sector: -65.32% Industry: -65.32%

ROIC

Sector: -2,916.46% Industry: -2,916.46%

ROA

-57.02%

Sector: -65.71% Industry: -65.71%

Net Debt / Equity

Sector: - Industry: -

Net Debt / EBITDA

Sector: - Industry: -

Net Debt / EBIT

Sector: - Industry: -

Gross Debt / Equity

Sector: - Industry: -

Equity / Assets

0.34

Sector: 0.42 Industry: 0.42

Liabilities / Assets

0.66

Sector: 0.40 Industry: 0.40

Current Ratio

Sector: - Industry: -

CAGR Revenue 5 Years

34.18%

Sector: - Industry: -

CAGR Profit 5 Years

22.19%

Sector: - Industry: -

Fundamentals INSM

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
INSM	-20.76	34.87	-167.94%	0.00%	$24.58 B	-100.00%
JNJ	29.36	7.61	25.92%	2.04%	$617.76 B	21.83%
PFE	18.09	1.50	8.29%	7.22%	$135.53 B	11.83%
ABBV	120.03	-65.99	-54.98%	2.73%	$436.32 B	5.79%
NVO	11.61	7.01	60.40%	3.75%	$220.17 B	37.15%
MRK	34.17	6.65	19.45%	2.72%	$305.30 B	13.59%
AZN	25.71	5.64	21.93%	1.86%	$267.10 B	17.19%
GILD	17.54	6.90	39.33%	2.47%	$161.68 B	30.99%
BMY	15.87	5.74	36.19%	4.41%	$115.47 B	15.01%
ZTS	12.23	10.00	81.75%	2.69%	$32.33 B	27.79%
REGN	15.58	2.19	14.08%	0.55%	$68.90 B	29.65%
HALO	25.79	40.96	158.82%	0.00%	$9.00 B	23.13%
AMGN	25.19	21.38	84.87%	2.69%	$196.47 B	20.96%
MCK	20.46	-116.82	-570.98%	0.41%	$97.43 B	1.18%
VRTX	28.50	6.39	22.41%	0.00%	$123.63 B	35.51%
CAH	35.40	-20.60	-58.20%	0.87%	$55.05 B	0.62%
HRMY	14.62	2.34	16.00%	0.00%	$2.13 B	16.20%
BIIB	21.22	1.56	7.36%	0.00%	$29.11 B	13.81%
MEDP	32.43	24.96	76.95%	0.00%	$14.93 B	17.19%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

INSM Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Insmed

Insmed Incorporated

Average Investor10 user rating

4.0 (12 people)

United States

27 years

Founded: 1999

2000

Time since IPO - 26 years

521

Employees

Insmed Incorporated (United States) is listed on the Nasdaq and has a market capitalization of $24.58 billion, with shareholders equity totaling $704.85 million.

The company employs approximately 521 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Insmed Incorporated reported $819.56 million in revenue, generating net income of $-1.18 billion.

Key financial metrics include a P/E ratio of -20.76, a price-to-book (P/B) ratio of 34.87, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker INSM.

Market cap

$24.58 billion

Net worth

$704.85 million

$704,852,000.00

Assets

$2.08 billion

$2,075,862,999.00

Total Shares Outstanding

215.47 million

215,468,000

Average Daily Trading Volume

$2.47 million

$2,473,350.00

Sector

Health Care

Industry

Biotechnology

INSM

revenue by Business Segment Insmed

Revenue by Region Insmed

INSM revenue and profits

Financial Results INSM

DRAG THE FRAME TO SEE MORE DATA

INSM cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$809.54 14,55% (12M)

P/E

20.46

0.41%

ROE

-570.98%

P/BV

-116.82

CAH - Cardinal Health

$234.31 47,54% (12M)

P/E

35.40

0.87%

ROE

-58.20%

P/BV

-20.60

JNJ - Johnson & Johnson

$258.33 68,78% (12M)

P/E

29.36

2.04%

ROE

25.92%

P/BV

7.61

MRK - Merck & Co.

$123.50 53,06% (12M)

P/E

34.17

2.72%

ROE

19.45%

P/BV

6.65

AZN - AstraZeneca

$169.03 19,87% (12M)

P/E

25.71

1.86%

ROE

21.93%

P/BV

5.64

ABBV - AbbVie

$246.35 33,22% (12M)

P/E

120.03

2.73%

ROE

-54.98%

P/BV

-65.99

NVO - Novo Nordisk

$49.41 --24,87% (12M)

P/E

11.61

3.75%

ROE

60.40%

P/BV

7.01

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$809.54 14,55% (12 M)

P/L

20.46

0.41%

ROE

-570.98%

P/VP

-116.82

CAH - Cardinal Health

$234.31 47,54% (12 M)

P/L

35.40

0.87%

ROE

-58.20%

P/VP

-20.60

JNJ - Johnson & Johnson

$258.33 68,78% (12 M)

P/L

29.36

2.04%

ROE

25.92%

P/VP

7.61

MRK - Merck & Co.

$123.50 53,06% (12 M)

P/L

34.17

2.72%

ROE

19.45%

P/VP

6.65

AZN - AstraZeneca

$169.03 19,87% (12 M)

P/L

25.71

1.86%

ROE

21.93%

P/VP

5.64

ABBV - AbbVie

$246.35 33,22% (12 M)

P/L

120.03

2.73%

ROE

-54.98%

P/VP

-65.99

NVO - Novo Nordisk

$49.41 --24,87% (12 M)

P/L

11.61

3.75%

ROE

60.40%

P/VP

7.01

Frequently Asked Questions

What is the price of Insmed (INSM) today?

The current price of Insmed (INSM) is $109.49. The stock began the year trading around $174.04 and is currently priced at $109.49. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Insmed (INSM) pay dividends?

Insmed (INSM) did not pay dividends over the past year.

Is Insmed (INSM) a good investment?

Insmed (INSM) is currently trading at $109.49 with a P/E ratio of -20.76. This represents a -1,574% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 11.52%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Insmed (INSM) stock?

You can buy Insmed (INSM) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol INSM and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Insmed (INSM) yield today?

Over the past month, Insmed (INSM) has returned 11.90% — 11.52% over the past year, and 299.74% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Insmed (INSM) today at the current price of $109.49 your total investment would be $10,949.00.

Based on historical performance, the investment would have grown to approximately:

$12,210.32 after 1 year
$43,767.53 after 5 years
$105,158.58 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

INSM

Insmed Incorporated

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment INSM

review the fundamentals of Insmed shares

P/E

P/Revenue (PSR)

P/BV

Dividend Yield (DY)

Payout

Net Profit Margins

Gross Margin

Operating Margin

EBIT Margin

EBITDA Margin

EV/EBITDA

EV/EBIT

P/EBITDA

P/EBIT

P/Total Assets

P/Working Capital

P/Net Current Assets

BVPS

EPS

Asset Turnover

ROE

ROIC

ROA

Net Debt / Equity

Net Debt / EBITDA

Net Debt / EBIT

Gross Debt / Equity

Equity / Assets

Liabilities / Assets

Current Ratio

CAGR Revenue 5 Years

CAGR Profit 5 Years

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Insmed

Insmed Incorporated

United States

27 years

2000

521

PROFIT X PRICE INSM

Financial Results INSM

INSM cash flow

Asset, Revenue and Profit Growth - INSM

INSM balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

Frequently Asked Questions